{"filing":{"accession_number":"0001683168-26-006815","cik":"0000882291","ticker":"AEMD","company_name":"AETHLON MEDICAL INC","form":"8-K","filing_date":"2026-08-31","report_date":"2026-08-28","primary_document":"aethlon_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/882291/000168316826006815/aethlon_8k.htm"},"events":[{"id":30535,"run_id":27985,"accession_number":"0001683168-26-006815","anchor_item_number":"8.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"summary":"The filing discloses exercise of pre-funded warrants resulting in 1,604,095 shares of common stock outstanding as of August 28, 2026, with all previously outstanding pre-funded warrants now exercised. Pre-funded warrant exercises represent dilutive equity issuances that increase share count and dilute existing shareholders, a material capital structure event for investors assessing ownership and voting power.","company_name":"AETHLON MEDICAL INC","ticker":"AEMD","filing_date":"2026-08-31","form":"8-K","submitted_at":null,"items":[{"id":33159,"accession_number":"0001683168-26-006815","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"The filing discloses exercise of pre-funded warrants resulting in 1,604,095 shares of common stock outstanding as of August 28, 2026, with all previously outstanding pre-funded warrants now exercised. Pre-funded warrant exercises represent dilutive equity issuances that increase share count and dilute existing shareholders, a material capital structure event for investors assessing ownership and voting power.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-31T13:16:52.924082+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":33159,"accession_number":"0001683168-26-006815","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"The filing discloses exercise of pre-funded warrants resulting in 1,604,095 shares of common stock outstanding as of August 28, 2026, with all previously outstanding pre-funded warrants now exercised. Pre-funded warrant exercises represent dilutive equity issuances that increase share count and dilute existing shareholders, a material capital structure event for investors assessing ownership and voting power.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-31T13:16:52.924082+00:00","company_name":"AETHLON MEDICAL INC","ticker":"AEMD","filing_date":"2026-08-31"}]}